Dr. Arlene Vance, Pioneer in mRNA Technology, Dies at 84
Decades before the pandemic, Dr. Vance's stubbornly funded lab work laid the groundwork for lipid nanoparticle delivery systems.
Timeline of Major Publications
| Year | Journal | Contribution |
|---|---|---|
| 1989 | Nature | First demonstration of synthetic mRNA translation in vivo. |
| 1994 | Cell | Identification of immune-evasion techniques for synthetic RNA. |
| 2005 | Science | Development of lipid nanoparticle encasement strategy. |
Related links: Future of mRNA, Vaccine development, Biotech patents, NIH funding, Computational biology, Global health, Scientific credit disputes, Women in STEM, University research parks, Patent filings, Funding basic research, Science communication, Synbio and climate, Other notable scientists, Peer review, Infectious diseases, Pharma acquisitions, Science policy, Lab automation, Nobel history, and Postdoc conditions.
Common Misconceptions about mRNA
- That it was developed 'overnight': The technology relies on over 30 years of incremental basic research before it was deployed commercially.
Obituaries FAQ
How does Express Mirror select obituaries?
We focus on individuals whose work had a systemic impact on politics, business, technology, or culture.
Next Step: Submit a notice to the local desk.